LymeNet Flash: Mepron patent expiring.

LymeNet on Facebook

LymeNet on Twitter

Follow @LymeDiseaseNet

The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive

The Lyme Disease Network is a non-profit organization funded by individual donations.

»	LymeNet Flash » Questions and Discussion » Medical Questions » Mepron patent expiring.

UBBFriend: Email this page to someone!

Author

Topic: Mepron patent expiring.

JamesNYC
LymeNet Contributor
Member # 15793

posted

I know some people have mentioned this. However, this is the first confirmation I have found.

The following is excerpted (and edited by me) from this article:

http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Patents-soon-to-expire-for-many-brand-name-drugs/ArticleStandard/Article/detail/617015

Going, going, gone
Patents set to expire soon on many brand-name drugs
Publish date: Aug 10, 2009
By: Kathy Method, Clinical Senior Editor, Centralized Content Group

Time is running out on the U.S. patents for many of the most popular brand-name drugs. Unless original exclusivity dates are somehow extended, over the next several years generic versions of many well-known best-selling drugs will become available.

Pharmacists will need to stay abreast of these changes as consumers struggling to cope with the high cost of prescription medications turn to them with the question "Is there a generic for that?" Increasingly, over the next several years, the answer will be yes.

Off patent in 2009 and 2010

Patents have already expired or are soon to expire in 2009 for several brand-name drugs.

From GlaxoSmithKline (GSK), the blockbuster Valtrex (valacyclovir hydrochloride) for the treatment of genital herpes and cold sores goes off patent this year. Teva has received tentative approval from the Food and Drug Administration (FDA) to begin marketing its generic version in December.1

Also going off patent is Mepron (atovaquone), GSK's antiprotozoal used for the treatment of pneumonia in patients with compromised immune systems. Mepron is also used to treat Lyme disease.

Posts: 872 | From New York City | Registered: Jun 2008 | IP: Logged |

ping
Frequent Contributor (1K+ posts)
Member # 6974

posted

Oh, thank you, James for posting this! My favorite, yellow, banana shake could actually get cheaper. Many of my friends can't afford it under patent. [woohoo]

ping
"We are more than containers for Lyme"

--------------------
ping
"We are more than containers for Lyme"

Posts: 1302 | From Back in TX again | Registered: Mar 2005 | IP: Logged |

coltman
LymeNet Contributor
Member # 21272

posted

Its great news ,unfortunately time to market is quite long and there will be a while till cheap generics become available.

Rocephin expired a while ago yet even generics are still very expensive

Posts: 856 | From MA | Registered: Jul 2009 | IP: Logged |

radfaraf
LymeNet Contributor
Member # 11909

posted

They have another patent related to that med expiring in 2019, not sure what that means for us.

http://www.patentstorm.us/patents/6649659/description.html

Posts: 526 | From NJ | Registered: May 2007 | IP: Logged |

Printer-friendly view of this topic

The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA
http://www.lymenet.org/